Federal Court of Appeal Upholds I-MED Pharma’s Patent Win Against TearLab
June 17, 2019 11:05 ET
|
I-MED Pharma
MONTREAL, June 17, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the Canadian Federal Court of Appeal...
I-MED Pharma Inc. Announces Partnership with Medicals International
July 23, 2018 11:41 ET
|
I-MED Pharma
MONTREAL, July 23, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with...
I-MED Pharma’s I-PEN® Receives Regulatory Approval from INVIMA in Colombia and ANMAT in Argentina
April 03, 2018 14:30 ET
|
I-MED Pharma
MONTREAL, April 03, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian Company specializing in dry eye diagnosis and management, is pleased to announce receiving regulatory approval from INVIMA...
I-MED Pharma Wins Patent Case Against TearLab
February 13, 2018 15:55 ET
|
I-MED Pharma
MONTREAL, Feb. 13, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., announced today that TearLab’s efforts to keep the I-PEN® Osmolarity System off the market proved unsuccessful. I-MED Pharma wins...
I-MED Pharma partners with OCuSOFT to bring the I-PEN® Osmolarity System to the U.S.A.
January 08, 2018 13:02 ET
|
I-MED Pharma
MONTREAL, Jan. 08, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with...
I-PEN®, I-DROP® et I-PLUG® maintenant offerts en Espagne et au Portugal grâce à un partenariat avec IMEX
January 08, 2018 09:16 ET
|
I-MED Pharma
MONTRÉAL, 08 janv. 2018 (GLOBE NEWSWIRE) -- I-MED Pharma inc., une entreprise canadienne spécialisée dans le diagnostic et la prise en charge de la sécheresse oculaire, a annoncé aujourd’hui la...
I-PEN®, I-DROP® and I-PLUG® now available in Spain and Portugal through Partnership with IMEX
January 08, 2018 09:16 ET
|
I-MED Pharma
MONTREAL, Jan. 08, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of an exclusive agreement with IMEX...
I-PEN®, I-DROP® et I-LID’N LASH® seront offerts au Danemark, en Suède et en Norvège
October 06, 2017 15:17 ET
|
I-MED Pharma
MONTRÉAL, 06 oct. 2017 (GLOBE NEWSWIRE) -- I-MED Pharma inc., annonce aujourd'hui la nomination de AMWO Farma IVS comme distributeur exclusif du système d'osmolarité lacrymale I-PEN® ainsi que...
I-PEN®, I-DROP® and I-LID’N LASH® will be available in Denmark, Sweden and Norway
October 06, 2017 15:17 ET
|
I-MED Pharma
MONTREAL, Oct. 06, 2017 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specialized in dry eye diagnosis and management, announced today the appointment of AMWO Farma IVS as its exclusive...
i-Pen® Tear Osmolarity System registered in Japan
September 19, 2017 14:45 ET
|
I-MED Pharma
MONTREAL, Sept. 19, 2017 (GLOBE NEWSWIRE) -- I-MED Pharma announced today the successful registration of its i-Pen® Tear Osmolarity System (“i-Pen®”) in Japan. The i-Pen® is an in-vivo handheld tear...